Skip to main content
logo
GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.0814
+0.0002 (0.25%)
At close: Feb 20, 2026

GenSight Biologics Revenue

GenSight Biologics had revenue of 48.00K EUR in the half year ending June 30, 2025, a decrease of -98.23%. This brings the company's revenue in the last twelve months to 945.00K, down -52.18% year-over-year. In the year 2024, GenSight Biologics had annual revenue of 2.63M, down -11.44%.

Revenue (ttm)
945.00K
Revenue Growth
-52.18%
P/S Ratio
18.99
Revenue / Employee
72.69K
Employees
13
Market Cap
17.95M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.63M-339.00K-11.44%
Dec 31, 20232.96M-1.90M-39.08%
Dec 31, 20224.87M-2.84M-36.89%
Dec 31, 20217.71M269.00K3.62%
Dec 31, 20207.44M2.53M51.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
genOway Société anonyme27.16M
Fermentalg12.78M
Poxel7.66M
Advicenne5.90M
Nicox3.32M
Aelis Farma2.33M
Plant Advanced Technologies2.22M
Oncodesign Precision Medicine Société anonyme1.74M
Revenue Rankings

GenSight Biologics News

More News